P28.41
Central neonatal apnea of newborn
Clinical Classification Guidelines
Medical Intelligence & Overview
Central neonatal apnea is a condition that affects newborns, characterized by the temporary cessation of breathing due to the brain's inability to send appropriate signals to the respiratory muscles. This disorder typically occurs within the first few days or weeks of life and requires attentive medical management to ensure the safety and health of the infant. Recognized under ICD-10 code P28.41, central neonatal apnea is a significant concern for healthcare providers and parents alike, emphasizing the importance of early detection and intervention.
Causes & Symptoms
Clinical Causes: Immature respiratory control centers in the brain Neurological abnormalities or injury Infections such as neonatal meningitis or encephalitis Metabolic disorders affecting the nervous system Prenatal exposure to certain substances like opioids Respiratory or cardiac conditions that impair oxygen delivery Genetic syndromes affecting neurological development
Key Symptoms: Episodes of paused or slowed breathing during sleep or wakefulness Blue or pale skin (cyanosis) during apnea episodes Lack of response to stimuli during episodes Irregular breathing patterns Poor feeding or difficulty feeding Lethargy or decreased activity Episodes of choking or gagging
Diagnostic & Treatment
Diagnosis Path: Monitoring the infant’s breathing patterns using respiratory and cardiac monitors Polysomnography (sleep study) to assess sleep-related breathing irregularities Brain imaging studies such as MRI if neurological injury is suspected Laboratory tests to check for metabolic or infectious causes Assessment of neurological reflexes and responses
Treatment Protocols: Supportive care with careful monitoring of breathing and oxygen levels Use of respiratory support devices such as ventilators or continuous positive airway pressure (CPAP) when necessary Addressing underlying conditions, such as infections or metabolic issues Pharmacologic treatments, such as the use of methylxanthines (e.g., caffeine) to stimulate breathing Ensuring a safe sleep environment to minimize risks during episodes Gradual weaning from medical support as the infant’s neurological control improves Follow-up with pediatric neurologists and respiratory specialists for ongoing care
Clinical Advice & FAQs
Billing Guidance
Is P28.41 a billable ICD-10 code?
Yes, P28.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P28.41?
Clinical documentation must specify the nature of Central neonatal apnea of newborn and any associated comorbidities for accurate reporting.
Cite this Clinical Reference